Some studies suggest that ARTN/GFRα3 signaling is involved in the pathogenesis of bone pain, and inhibition of this process could be used to treat pain in osteoarthritis (OA) when pathological features are present in the subchondral bone (38, 39). The gene discussed is ARTN; the disease is osteoarthritis.